Related Experiment Video
Updated: Jun 10, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
[Involvement of MAPK pathway in the osteoblastic differentiation of mouse mesenchymal stem cells]
Wei-Xia Kong1, Heng Zhu, Xiao-Xia Jiang
1Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China.
Abstract:
This study was purposed to investigate the effect of mitogen-activated protein kinase (MAPK) pathway on the osteoblast differentiation of mouse mesenchymal stem cells (MSCs), MSCs were isolated from mouse compact bone and serially passaged. After being cultured in osteogenic induction medium, the phosphorylation levels of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 were detected by Western blot. The effects of corresponding pathway inhibitors including PD98059, JNK II and SB203580 on alkaline phosphatase (ALP) and calcium accumulation in the osteoblastic differentiation of MSCs were determined by ALP staining and von kossa staining respectively. The results showed that MAPK pathway including ERK, JNK and p38 was activated in differentiation of MSCs into osteoblasts. ALP activity of MSCs increased in the early phase by addition of PD98059 treatment, whereas ALP activity and calcium accumulation were not observed via JNK II treatment. However, SB203580 strongly inhibited the ALP expression and the calcium accumulation. It is concluded that p38 plays a positive role in the osteogenic differentiation of MSCs, and ERK is probably a negative factor at the early phase of differentiation, but the effect of JNK is not essential.
Insights
Mitogen-activated protein kinase (MAPK) signaling, including p38 and extracellular signal-regulated kinase (ERK), influences mouse mesenchymal stem cell (MSC) osteoblast differentiation. P38 promotes differentiation, while ERK may inhibit it early on.
Area of Science:
- Cell Biology
- Biochemistry
- Stem Cell Research
Background:
- Mesenchymal stem cells (MSCs) are crucial for bone regeneration.
- Osteoblast differentiation is a complex process regulated by signaling pathways.
- The role of mitogen-activated protein kinase (MAPK) pathways in osteogenesis requires further elucidation.
Purpose of the Study:
- To investigate the impact of the MAPK pathway on osteoblast differentiation in mouse MSCs.
- To determine the specific roles of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 in this process.
Main Methods:
- Isolation and culture of mouse MSCs.
- Western blot analysis to detect MAPK pathway activation (ERK, JNK, p38 phosphorylation).
- Inhibition of MAPK pathways using PD98059 (ERK), JNK II (JNK), and SB203580 (p38).
- Assessment of osteoblast differentiation via alkaline phosphatase (ALP) staining and von Kossa staining for calcium accumulation.
Main Results:
- MAPK pathway components (ERK, JNK, p38) were activated during MSC osteogenic differentiation.
- PD98059 treatment increased ALP activity in early differentiation.
- JNK II treatment showed no significant effect on ALP activity or calcium accumulation.
- SB203580 treatment significantly inhibited ALP expression and calcium accumulation.
Conclusions:
- The p38 pathway plays a positive role in MSC osteogenic differentiation.
- The ERK pathway may act as a negative regulator during the early stages of differentiation.
- The JNK pathway's role in MSC osteogenic differentiation appears non-essential.
Related Concept Videos
MAPK Signaling Cascades
Mesenchymal Stem Cells

